Abstract | BACKGROUND/AIM: Anticancer efficacy of vitamin K derivatives on multidrug-resistant cancer cells has been scarcely investigated. MATERIALS AND METHODS: RESULTS:
Vitamins K3 and K5 significantly inhibited proliferation of leukemic cells at 10 and 100 μM (p<0.05), and these effects were almost equally observed in both MOLT-4 and MOLT/DNR drug-resistant cells. Vitamin K3 induced cell apoptosis at 10 and 100 μM in both MOLT-4 and MOLT-4/DNR cells (p<0.05). Vitamin K5 also increased apoptotic cells, while rather inducing necrotic cell death. CONCLUSION:
Vitamins K3 and K5 suppress MOLT-4 and MOLT-4/DNR cell-proliferation partially through induction of apoptosis, and these vitamin derivatives can overcome drug resistance due to P-glycoprotein expression.
|
Authors | Eri Nakaoka, Sachiko Tanaka, Kenji Onda, Kentaro Sugiyama, Toshihiko Hirano |
Journal | Anticancer research
(Anticancer Res)
Vol. 35
Issue 11
Pg. 6041-8
(Nov 2015)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 26504027
(Publication Type: Journal Article)
|
Copyright | Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antibiotics, Antineoplastic
- Vitamins
- Vitamin K 3
- vitamin k5
- Daunorubicin
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(metabolism)
- Antibiotics, Antineoplastic
(pharmacology)
- Apoptosis
(drug effects)
- Cell Proliferation
(drug effects)
- Daunorubicin
(pharmacology)
- Drug Resistance, Multiple
(drug effects)
- Drug Resistance, Neoplasm
(drug effects)
- Flow Cytometry
- Humans
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy, metabolism, pathology)
- Tumor Cells, Cultured
- Vitamin K 3
(analogs & derivatives, pharmacology)
- Vitamins
(pharmacology)
|